Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension

2005 ◽  
Vol 14 (10) ◽  
pp. 30
Author(s):  
O. Sitbon ◽  
M. Humbert ◽  
X. Jäis
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Calcium Channel ◽  
Calcium Channel Blockers ◽  
Idiopathic Pulmonary Arterial Hypertension ◽  
Channel Blockers ◽  
Pulmonary Arterial ◽  
Term Response

scholarly journals Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension

Circulation ◽  
2005 ◽  
Vol 111 (23) ◽  
pp. 3105-3111 ◽  
Author(s):  
Olivier Sitbon ◽  
Marc Humbert ◽  
Xavier Jaïs ◽  
Vincent Ioos ◽  
Abdul M. Hamid ◽  
...  
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Calcium Channel ◽  
Calcium Channel Blockers ◽  
Idiopathic Pulmonary Arterial Hypertension ◽  
Channel Blockers ◽  
Pulmonary Arterial ◽  
Term Response

scholarly journals Long-Term Survival in Idiopathic Pulmonary Arterial Hypertension Associated with Massive Pulmonary Artery Dilation

2011 ◽  
Vol 18 (3) ◽  
pp. e50-e51 ◽  
Author(s):  
Vanja Petrovic ◽  
Christopher J Ryerson ◽  
Robert D Levy
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Present Report ◽  
Pulmonary Arteries ◽  
Idiopathic Pulmonary Arterial Hypertension ◽  
Channel Blockers ◽  
Term Survival ◽  
Long Term Survival ◽  
Pulmonary Arterial

The present report describes two patients with long-term survival after being diagnosed with idiopathic pulmonary arterial hypertension more than 20 years earlier. Both patients were treated with calcium channel blockers for several years and are currently maintained on bosentan, an oral endothelin receptor antagonist. Severe dilation of the main pulmonary arteries is present in both patients and may be related to long-term survival with idiopathic pulmonary arterial hypertension.

Sign in / Sign up

Export Citation Format

Share Document